Hero image with Pittsburgh background pittplusme.org/study/1739

STUDY BASICS

Do you have chronic hand eczema? If so, you may be able to participate in a study to evaluate the safety and efficacy (how well something works) of a study drug called ARQ-252 cream in people who have chronic hand eczema. This study includes up to 7 in-person visits over 17 weeks. Compensation is provided.


IRB:
  20200603 - A Phase 1/2b, Multiple Dose and 12-Week, Parallel Group, Double Blind, Dose Ranging, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-252 Cream 0.1% and ARQ-252 Cream 0.3% in Subjects with Chronic Hand Eczema

RESEARCH AREAS:
  Featured Research

Age Range
AGE:   18 and up

Duration DURATION:  Up to 17 weeks
VISITS:  Up to 7 in-person visits

Location LOCATION: 
Falk Medical Building - Oakland
Compensation COMPENSATION: 

$52 per visit

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1739
OR
Phone Number PHONE NUMBER:
1-866-438-8230

MEET THE RESEARCHER


Laura Ferris

Laura Korb Ferris, MD, PhD, is Associate Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.




PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet